Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 10Thoracic 2Other hematologic neoplasm 2Gynecologic 2Genitourinary 2Endocrine 2Plasma cell 1Myeloid 1Lymphoid 1Head & Neck 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 100Leukemia, Myeloid, Acute 93Precursor Cell Lymphoblastic Leukemia-Lymphoma 74Myeloproliferative Disorders 71Multiple Myeloma 65Lymphoma, Non-Hodgkin 62Leukemia 62Leukemia, Myelogenous, Chronic, BCR-ABL Positive 60Leukemia, Lymphocytic, Chronic, B-Cell 58Hodgkin Disease 58Primary Myelofibrosis 52Lymphoma, Mantle-Cell 45Lymphoma, Large B-Cell, Diffuse 42Burkitt Lymphoma 42Lymphoma, Follicular 41Leukemia, Myeloid, Chronic-Phase 40Lymphoma, B-Cell, Marginal Zone 39Lymphoma 39Lymphoma, Large-Cell, Immunoblastic 38Congenital Abnormalities 37Lymphoma, T-Cell, Cutaneous 35Leukemia, Myeloid, Accelerated Phase 35Sezary Syndrome 32Mycosis Fungoides 32Leukemia, Myelomonocytic, Chronic 32Blast Crisis 32Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 28Pdgfra-Associated Chronic Eosinophilic Leukemia 27Leukemia, Neutrophilic, Chronic 27Neoplasms, Plasma Cell 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Treatment Adherence and Compliance × Myeloid × Clear all
NCT05260203 2024-11-06

MargheRITA

Advice Pharma Group srl

Phase NA Completed
124 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Treatment Adherence and Compliance, Amyloidosis, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡